| Drug Name | Azithromycin |
|---|---|
| Drug Class |
Antibiotic
|
| Risk minimization type |
Direct Healthcare Professional Communication DHPC
Safety communication
|
| Specialty (Theraputic area) |
Infectious disease
|
| Risk |
Risk of Hematological Relapses and Deaths Associated with Long-Term Use of Azithromycin Following Hematopoietic Stem Cell Transplant . increased rate of relapses hematological malignancies and mortality in hematopoietic stem cell transplantation patients. |
| safety communication |
|
| Dear Healthcare provider letter DHPC |
|